Critical care management of aneurysmal subarachnoid haemorrhage in Australia and New Zealand

What are we doing, and where to from here?

Andrew A. Udy, Sacha Schweikert, James R Anstey, Matthew Anstey, Jeremy Cohen, Oliver Flower, Edward Robert Saxby, Andrew Van Der Poll, Anthony Delaney

Research output: Contribution to journalArticleOtherpeer-review

Abstract

Patients with an aneurysmal subarachnoid haemorrhage (SAH) frequently require admission to the intensive care unit. There, a variety of therapeutic strategies are initiated, in addition to definitive procedures aimed at securing the aneurysm. • Despite a substantial investment in caring for these patients, outcomes for this group remain poor. Although the severity of the initial bleed is crucial in this context, many patients undergo further deterioration in the ICU. Delayed cerebral ischaemia is a significant cause of long-term morbidity and mortality after SAH. • There are limited data supporting much of the critical care provided to patients with SAH in the ICU, leading to substantial institutional and practitioner variation in treatment. Whether this influences patient outcomes is unknown, although it represents a major knowledge gap in neurocritical practice in Australia and New Zealand.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalCritical Care and Resuscitation
Volume19
Issue number2
Publication statusPublished - 2017

Cite this

Udy, Andrew A. ; Schweikert, Sacha ; Anstey, James R ; Anstey, Matthew ; Cohen, Jeremy ; Flower, Oliver ; Saxby, Edward Robert ; Van Der Poll, Andrew ; Delaney, Anthony. / Critical care management of aneurysmal subarachnoid haemorrhage in Australia and New Zealand : What are we doing, and where to from here?. In: Critical Care and Resuscitation. 2017 ; Vol. 19, No. 2. pp. 103-109.
@article{cc47690aa11e40ba9223a7aabaccde35,
title = "Critical care management of aneurysmal subarachnoid haemorrhage in Australia and New Zealand: What are we doing, and where to from here?",
abstract = "Patients with an aneurysmal subarachnoid haemorrhage (SAH) frequently require admission to the intensive care unit. There, a variety of therapeutic strategies are initiated, in addition to definitive procedures aimed at securing the aneurysm. • Despite a substantial investment in caring for these patients, outcomes for this group remain poor. Although the severity of the initial bleed is crucial in this context, many patients undergo further deterioration in the ICU. Delayed cerebral ischaemia is a significant cause of long-term morbidity and mortality after SAH. • There are limited data supporting much of the critical care provided to patients with SAH in the ICU, leading to substantial institutional and practitioner variation in treatment. Whether this influences patient outcomes is unknown, although it represents a major knowledge gap in neurocritical practice in Australia and New Zealand.",
author = "Udy, {Andrew A.} and Sacha Schweikert and Anstey, {James R} and Matthew Anstey and Jeremy Cohen and Oliver Flower and Saxby, {Edward Robert} and {Van Der Poll}, Andrew and Anthony Delaney",
year = "2017",
language = "English",
volume = "19",
pages = "103--109",
journal = "Critical Care and Resuscitation",
issn = "1441-2772",
publisher = "Australasian Medical Publishing Co. Pty Ltd. (AMPCo)",
number = "2",

}

Udy, AA, Schweikert, S, Anstey, JR, Anstey, M, Cohen, J, Flower, O, Saxby, ER, Van Der Poll, A & Delaney, A 2017, 'Critical care management of aneurysmal subarachnoid haemorrhage in Australia and New Zealand: What are we doing, and where to from here?', Critical Care and Resuscitation, vol. 19, no. 2, pp. 103-109.

Critical care management of aneurysmal subarachnoid haemorrhage in Australia and New Zealand : What are we doing, and where to from here? / Udy, Andrew A.; Schweikert, Sacha; Anstey, James R; Anstey, Matthew; Cohen, Jeremy; Flower, Oliver; Saxby, Edward Robert; Van Der Poll, Andrew; Delaney, Anthony.

In: Critical Care and Resuscitation, Vol. 19, No. 2, 2017, p. 103-109.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Critical care management of aneurysmal subarachnoid haemorrhage in Australia and New Zealand

T2 - What are we doing, and where to from here?

AU - Udy, Andrew A.

AU - Schweikert, Sacha

AU - Anstey, James R

AU - Anstey, Matthew

AU - Cohen, Jeremy

AU - Flower, Oliver

AU - Saxby, Edward Robert

AU - Van Der Poll, Andrew

AU - Delaney, Anthony

PY - 2017

Y1 - 2017

N2 - Patients with an aneurysmal subarachnoid haemorrhage (SAH) frequently require admission to the intensive care unit. There, a variety of therapeutic strategies are initiated, in addition to definitive procedures aimed at securing the aneurysm. • Despite a substantial investment in caring for these patients, outcomes for this group remain poor. Although the severity of the initial bleed is crucial in this context, many patients undergo further deterioration in the ICU. Delayed cerebral ischaemia is a significant cause of long-term morbidity and mortality after SAH. • There are limited data supporting much of the critical care provided to patients with SAH in the ICU, leading to substantial institutional and practitioner variation in treatment. Whether this influences patient outcomes is unknown, although it represents a major knowledge gap in neurocritical practice in Australia and New Zealand.

AB - Patients with an aneurysmal subarachnoid haemorrhage (SAH) frequently require admission to the intensive care unit. There, a variety of therapeutic strategies are initiated, in addition to definitive procedures aimed at securing the aneurysm. • Despite a substantial investment in caring for these patients, outcomes for this group remain poor. Although the severity of the initial bleed is crucial in this context, many patients undergo further deterioration in the ICU. Delayed cerebral ischaemia is a significant cause of long-term morbidity and mortality after SAH. • There are limited data supporting much of the critical care provided to patients with SAH in the ICU, leading to substantial institutional and practitioner variation in treatment. Whether this influences patient outcomes is unknown, although it represents a major knowledge gap in neurocritical practice in Australia and New Zealand.

UR - http://www.scopus.com/inward/record.url?scp=85023768739&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 103

EP - 109

JO - Critical Care and Resuscitation

JF - Critical Care and Resuscitation

SN - 1441-2772

IS - 2

ER -